While Mehta embraced the work-from-home lifestyle, the one thing that didn't change was his morning tea ritual. A tea lover, his favourite pastime is blending tea

Lack of semiconductor manufacturing is turning out to be the biggest hurdle in India's tryst with self-reliance in electronics. It requires 'out of the box' thinking by government and industry

The New Year raises new hopes, new expectations, new aspirations - even new anxieties. Finance Minister Nirmala Sitharaman has raised hopes by inviting ideas to spur growth with a promise to deliver \"a Budget like never before\"

How the FM can make it a 'never before' Budget. Top experts weigh in

Governments are introducing new lockdown measures to halt the spread while facing massive demand for vaccines which are seen as the best way out of the global health crisis

Many lessons have been learnt by the healthcare sector during the duration of the pandemic. Speaking to Rajeev Dubey, Editor, Business Today, Dr Krishna Ella, chairman of Bharat Biotech elaborated on the future of healthcare in the country and the lessons that have been learnt. Dr Ella looks forward to a national task force on the pandemic to plug the gaps in healthcare. Watch the video for more.

Bhopal gas activist Rachna Dhingra through a tweet on Sunday had alleged that poor and vulnerable residents of gas affected communities were herded by the People's University with a promise of Rs 750

Dr Krishna Ella, Bharat Biotech chairman spoke to Business Today editor Rajeev Dubey about the efficacy of Covaxin and what makes it safe for use. He said his vaccine was stable and they had data for four months to substantiate the claim. Watch the video for more.

As urbanisation and deforestation takes place, and global travel increases, viruses get the right environment to mutate and thereby grow. In such a situation how can one prepare for the future ? Watch as Dr Krishna Ella, chairman, Bharat Biotech, shares his views with Business Today editor, Rajeev Dubey.

As urbanisation and deforestation takes place, and global travel increases, viruses get the right environment to mutate and thereby grow. In such a situation how can one prepare for the future ? Watch as Dr Krishna Ella, chairman, Bharat Biotech, shares his views with Business Today editor, Rajeev Dubey.

Talking to BusinessToday.In, Dr. Krishna Ella, Chairman and MD, Bharat Biotech, said the trial would take around four months and if the regulator gives quick permission the company might start with the clinical trial

As the world waits with baited breath for the right vaccine for COVID-19, parents of children below the age of 16 are worried as the current vaccines cannot be administered to children below the age of 16. But Bharat Biotech chairman Dr Krishna Ella quelled their anxiety by revealing that the company was working towards a vaccine for those between the ages of 2 to 12 years. The trial for such a vaccine would take 3-4 months once the regulator gives its nod. Watch the video for more

Shares of Rail Vikas Nigam Ltd (RVNL) have gained 178 per cent from its 52-week low of Rs 10.20 as on March 24, 2020 on the back of strong earnings outlook along with the government's disinvestment bid

World Health Organisation (WHO) Director-General Tedros Adhanom Gheberyesus hailed India's coronavirus vaccine efforts on Tuesday, saying India continues to show its resolve to end the COVID-19 pandemic. On the other hand, Microsoft co-founder and Bill & Melinda Gates Foundation co-chairman, Bill Gates also appreciated India's efforts against coronavirus, after Prime Minister Narendra Modi's announcement of India being ready to launch the world's biggest vaccination drive against coronavirus. Watch the video for more.

It's great to see India's leadership in scientific innovation and vaccine manufacturing capability as the world works to end the COVID-19 pandemic, tweets the billionaire philanthropist

Rishad Premji wrote that his grandmother Gulbanoo helped to establish a children's hospital and his grandfather MH Hasham Premji founded Western India Vegetable Prdts, later Wipro

COVID-19 vaccine update: India has approved two coronavirus vaccines for emergency use - Bharat Biotech-ICMR's Covaxin and Covishield manufactured by Pune's Serum Institute

Patna airport had given the list of passengers who came from the UK between November 23 and December 31 and their addresses. But when health officials went to their houses to put them under quarantine, they found the people were missing

Without naming Serum Institute CEO Adar Poonawalla, who had termed vaccines other than that of Pfizer, Moderna and Oxford-AstraZeneca as 'just like water', Krishna Ella said, 'We do 200 per cent honest clinical trials and yet we receive backlash'

Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine, Bharat Biotech did not try to supress the side effects of vaccine by giving paracetamol to the volunteers